GGrantIndex
← Leaderboards

Guohong Li

Louisiana State Univ Hsc Shreveport

Google Scholar ↗PubMed ↗ORCID ↗
$10,592,248
Attributed
$10,592,248
Total exposure
6
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.3M · FY2008–25
$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,592,248 · 6

By mechanism

R01$9,992,248 · 5
S10$600,000 · 1

Top collaborators

No co-investigators on record.

Most similar at Louisiana State Univ Hsc Shreveport

Same institution · by research overlap

Others in their field

Top investigators on “Mediating”

Research focus

MediatingBrain InjuriesInjuryAcuteIschemic StrokeStrokeBrainMolecularResponseInflammatory ResponsePost StrokeCerebral IschemiaAnimal ModelBaseAlzheimer&AposInflammationReperfusion TherapyReportingHourInsightAcute StrokeIntravenousSecondary ToProteins

Grant awards (24)

A New Molecular Target to Enhance Poststroke Cognitive Recovery$698,892
R01 · FY2025 · NS · contact PI
Novel Targets and Therapeutic Interventions against Cerebral Ischemia-Reperfusion Injury$601,657
R01 · FY2025 · NS · contact PI
A New Molecular Target to Enhance Poststroke Cognitive Recovery$687,467
R01 · FY2024 · NS · contact PI
Novel Targets and Therapeutic Interventions against Cerebral Ischemia-Reperfusion Injury$583,607
R01 · FY2024 · NS · contact PI
A New Molecular Target to Enhance Poststroke Cognitive Recovery$668,216
R01 · FY2023 · NS · contact PI
Novel Targets and Therapeutic Interventions against Cerebral Ischemia-Reperfusion Injury$601,657
R01 · FY2023 · NS · contact PI
Novel Targets and Therapeutic Interventions against Cerebral Ischemia-Reperfusion Injury$597,643
R01 · FY2022 · NS · contact PI
Novel Targets and Therapeutic Interventions against Cerebral Ischemia-Reperfusion Injury$597,643
R01 · FY2021 · NS · contact PI
Combined Ultrasound and Multispectral Optoacoustic Tomography System for Imaging Small Animals$600,000
S10 · FY2019 · OD · contact PI
Therapeutic Targeting of the Class IB PI3-Kinase Gamma for Treatment of Acute Ischemic Stroke$339,719
R01 · FY2019 · NS · contact PI
The Role of CD147 in Ischemic Inflammation and Brain Injury$339,719
R01 · FY2018 · NS · contact PI
Therapeutic Targeting of the Class IB PI3-Kinase Gamma for Treatment of Acute Ischemic Stroke$339,719
R01 · FY2018 · NS · contact PI
The Role of CD147 in Ischemic Inflammation and Brain Injury$339,719
R01 · FY2017 · NS · contact PI
Therapeutic Targeting of the Class IB PI3-Kinase Gamma for Treatment of Acute Ischemic Stroke$339,719
R01 · FY2017 · NS · contact PI
The Role of CD147 in Ischemic Inflammation and Brain Injury$339,719
R01 · FY2016 · NS · contact PI
Therapeutic Targeting of the Class IB PI3-Kinase Gamma for Treatment of Acute Ischemic Stroke$339,719
R01 · FY2016 · NS · contact PI
The role of CD147 in ischemic inflammation and brain injury$317,188
R01 · FY2015 · NS · contact PI
Therapeutic targeting of the class IB PI3-kinase gamma for treatment of acute ischemic stroke$317,188
R01 · FY2015 · NS · contact PI
The role of CD147 in ischemic inflammation and brain injury$317,188
R01 · FY2014 · NS · contact PI
Mechanisms of CD40/CD40L in vascular injury and repair$310,665
R01 · FY2013 · HL · contact PI
Mechanisms of CD40/CD40L in vascular injury and repair$326,329
R01 · FY2012 · HL · contact PI
Mechanisms of CD40/CD40L in vascular injury and repair$329,625
R01 · FY2010 · HL · contact PI
Mechanisms of CD40/CD40L in vascular injury and repair$329,625
R01 · FY2009 · HL · contact PI
Mechanisms of CD40/CD40L in vascular injury and repair$329,625
R01 · FY2008 · HL · contact PI